Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-12-15

Clinical Trial Update: Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy [Phase 4]

View source ↗

Summary

Phase 4 trial on prophylactic antibiotics for surgical site infections in patients with beta-lactam allergy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Surgical Site Infection, Beta-lactam Allergy | Phase 4 | Status: WITHDRAWN